Hexo (TSE:HEXO) had its price objective raised by stock analysts at BMO Capital Markets from C$6.00 to C$9.00 in a report issued on Friday. BMO Capital Markets’ price target indicates a potential upside of 10.43% from the company’s previous close.
A number of other equities analysts have also recently issued reports on HEXO. Oppenheimer started coverage on shares of Hexo in a research report on Tuesday, February 19th. They set an “outperform” rating and a C$7.00 price objective on the stock. CIBC reissued an “outperform” rating and set a C$8.50 price objective on shares of Hexo in a research report on Tuesday, February 19th. Finally, Jefferies Financial Group reissued an “underperform” rating and set a C$5.60 price objective on shares of Hexo in a research report on Monday, February 25th.
Shares of HEXO stock traded up C$0.04 on Friday, reaching C$8.15. 2,862,740 shares of the company were exchanged, compared to its average volume of 3,485,671. The stock has a market capitalization of $1.67 billion and a PE ratio of -38.44. Hexo has a one year low of C$3.34 and a one year high of C$9.29.
Hexo Company Profile
HEXO Corp., through its subsidiary, HEXO Operations Inc, produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names.
Featured Story: Candlestick
Receive News & Ratings for Hexo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hexo and related companies with MarketBeat.com's FREE daily email newsletter.